-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B77gdztqgO7xWRIL1NFYvvMSP7Vw4ihayykXMnpMgvokejoSB7JYilO+D+0PV9OH QSpi8N0OJ0e8l3PiOJ2PSQ== 0000950117-02-000328.txt : 20020414 0000950117-02-000328.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950117-02-000328 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020214 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-04802 FILM NUMBER: 02545204 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K 1 a32086.txt BECTON, DICKINSON & CO. 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 14, 2002 ----------------- BECTON, DICKINSON AND COMPANY - ------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - ------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - ------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - ------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 5. OTHER EVENTS On February 14, 2002 the Registrant confirmed in a press release the election of Edward J. Ludwig to the additional role of Chairman of the Board effective following the Annual Meeting of Shareholders that was held on February 13, 2002. A copy of the press release is attached as Exhibit 99.1. Item 7. FINANCIAL STATEMENTS PRO FORMA FINANCIAL INFORMATION AND EXHIBITS Exhibit 99--Press release dated February 14, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Kathleen M. Gibson ---------------------------- Kathleen M. Gibson Assistant Secretary Date: February 14, 2002 - 2 - INDEX TO EXHIBITS
Exhibit Number Description of Exhibit ------ ---------------------- 99 Press release dated February 14, 2002.
EX-99 3 ex99.txt EXHIBIT 99 Contact: - -------- Dean J. Paranicas/ Investor and Media Relations 201-847-7102 Alexander Samuelson, Rubenstein Associates 212-843-8286 EDWARD J. LUDWIG BECOMES BD CHAIRMAN OF THE BOARD Franklin Lakes, NJ (February 14, 2002) - BD (Becton, Dickinson and Company) (NYSE: BDX) announced that Edward J. Ludwig was named Chairman of the Board, effective immediately following the BD Annual Meeting of Shareholders that was held yesterday. Mr. Ludwig succeeds Clateo Castellini, who will continue to serve as a member of the Board. As previously announced, in addition to serving as Chairman, Mr. Ludwig, 50, continues as BD's President and Chief Executive Officer. He has been President since June 1999 and Chief Executive Officer since January 2000. Mr. Ludwig joined the Company in 1979. BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2001, BD reported total revenues of $3.8 billion. -----END PRIVACY-ENHANCED MESSAGE-----